MAPT and Alzheimer disease: The amyloid cascade hypothesis of AD postulates that the pathologic process initiates with amyloid deposition (as measured by CSF Aβ42 and Aβ-PET), followed by changes in CSF tau proteins, then changes in FDG-PET and structural MRI, followed by cognitive symptoms [44, 62].